These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 16236078
1. The management of lichen planus with low-molecular-weight heparin (enoxaparin). Akdeniz S, Harman M, Atmaca S, Yaldiz M. Int J Clin Pract; 2005 Nov; 59(11):1268-71. PubMed ID: 16236078 [Abstract] [Full Text] [Related]
2. Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report. Hodak E, Yosipovitch G, David M, Ingber A, Chorev L, Lider O, Cahalon L, Cohen IR. J Am Acad Dermatol; 1998 Apr; 38(4):564-8. PubMed ID: 9555795 [Abstract] [Full Text] [Related]
3. Successful treatment of lichen planus with low-molecular-weight heparin: a case series of seven patients. Pacheco H, Kerdel F. J Dermatolog Treat; 2001 Jun; 12(2):123-6. PubMed ID: 12243672 [Abstract] [Full Text] [Related]
4. Successful treatment of lichen planus with sulfasalazine in 20 patients. Bauzá A, España A, Gil P, Lloret P, Vázquez Doval FJ. Int J Dermatol; 2005 Feb; 44(2):158-62. PubMed ID: 15689219 [Abstract] [Full Text] [Related]
6. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively. Pleym H, Videm V, Wahba A, Asberg A, Amundsen T, Bjella L, Dale O, Stenseth R. Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258 [Abstract] [Full Text] [Related]
7. Oral metronidazole treatment of lichen planus. Büyük AY, Kavala M. J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):260-2. PubMed ID: 10906648 [Abstract] [Full Text] [Related]
8. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage. Tetri S, Hakala J, Juvela S, Saloheimo P, Pyhtinen J, Rusanen H, Savolainen ER, Hillbom M. Thromb Res; 2008 Aug; 123(2):206-12. PubMed ID: 18420258 [Abstract] [Full Text] [Related]
9. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy. Narin C, Reyhanoglu H, Tülek B, Onoglu R, Ege E, Sarigül A, Yeniterzi M, Durmaz I. Adv Ther; 2008 Jun; 25(6):585-94. PubMed ID: 18568442 [Abstract] [Full Text] [Related]
10. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Zezos P, Papaioannou G, Nikolaidis N, Patsiaoura K, Papageorgiou A, Vassiliadis T, Giouleme O, Evgenidis N. Aliment Pharmacol Ther; 2006 May 15; 23(10):1443-53. PubMed ID: 16669959 [Abstract] [Full Text] [Related]
11. Sodium enoxaparin treatment of sensorineural hearing loss: an immune-mediated response? Mora R, Jankowska B, Passali GC, Mora F, Passali FM, Crippa B, Quaranta N, Barbieri M. Int Tinnitus J; 2005 May 15; 11(1):38-42. PubMed ID: 16419687 [Abstract] [Full Text] [Related]
12. The successful treatment of palmoplantar hyperkeratotic lichen planus with enoxaparin. Yasar S, Serdar ZA, Goktay F, Doner N, Tanzer C, Akkaya D, Gunes P. Indian J Dermatol Venereol Leprol; 2011 May 15; 77(1):64-6. PubMed ID: 21220884 [No Abstract] [Full Text] [Related]
13. Low-dose low-molecular-weight heparin in lichen planus. Rai R, Kaur I, Kumar B. J Am Acad Dermatol; 2002 Jan 15; 46(1):141-3. PubMed ID: 11756963 [No Abstract] [Full Text] [Related]
14. The use of sodium enoxaparin in the treatment of tinnitus. Mora R, Salami A, Barbieri M, Mora F, Passali GC, Capobianco S, Magnan J. Int Tinnitus J; 2003 Jan 15; 9(2):109-11. PubMed ID: 15106284 [Abstract] [Full Text] [Related]
15. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease. Chen JL, Chen J, Qiao SB, Guo YL, Wu YJ, Dai J, Yuan JQ, Qin XW, Yang YJ, Gao RL. Chin Med J (Engl); 2006 Mar 05; 119(5):355-9. PubMed ID: 16542576 [Abstract] [Full Text] [Related]
16. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. van Doormaal FF, Raskob GE, Davidson BL, Decousus H, Gallus A, Lensing AW, Piovella F, Prins MH, Büller HR. Thromb Haemost; 2009 Apr 05; 101(4):762-9. PubMed ID: 19350123 [Abstract] [Full Text] [Related]
17. [Use of low molecular weight heparin (Clexane) together with selective COX-2 inhibitor (Dynastat--once or twice per day)]. Tablov B, Ruseva A, Tablov V, Popov I, Stoĭkov S. Akush Ginekol (Sofiia); 2005 Apr 05; 44(5):31-4. PubMed ID: 16313051 [Abstract] [Full Text] [Related]
18. Treatment of severe cutaneous ulcerative lichen planus with low molecular weight heparin in a patient with hepatitis C. Neville JA, Hancox JG, Williford PM, Yosipovitch G. Cutis; 2007 Jan 05; 79(1):37-40. PubMed ID: 17330620 [Abstract] [Full Text] [Related]
19. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients]. Omran H, Hammerstingl C, Paar WD, Bonn Registry of Alternative Anticoagulation to Prevent Vascular Events. Med Klin (Munich); 2007 Oct 15; 102(10):809-15. PubMed ID: 17928964 [Abstract] [Full Text] [Related]
20. Efficacy of oral metronidazole in treatment of cutaneous and mucosal lichen planus. Rasi A, Behzadi AH, Davoudi S, Rafizadeh P, Honarbakhsh Y, Mehran M, Piran P, Dehghan N. J Drugs Dermatol; 2010 Oct 15; 9(10):1186-90. PubMed ID: 20941941 [Abstract] [Full Text] [Related] Page: [Next] [New Search]